NEW YORK (360Dx) – Chembio Diagnostics today said that the Brazilian health regulatory agency Agência Nacional de Vigilância Sanitária (ANVISA) approved the commercial use of the firm's DPP Micro Reader in that country, in collaboration with Bio-Manguinhos.

Chembio noted that because of the approval, its DPP Zika System, which includes a Zika IgM/IgG assay along with the micro reader, is also cleared for commercial use in Brazil.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.